Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sappanwood is a traditional Chinese medicine (TCM) derived from the dried heartwood of *Caesalpinia sappan* L. It contains several bioactive polyphenolic compounds, most notably brazilin, protosappanin A, protosappanin B, and hematoxylin. Pharmacologically, it is recognized for its antioxidant, anti-inflammatory, antibacterial, and iron-chelating properties. Recent research has explored its potential in treating iron overload in thalassemia, inhibiting SARS-CoV-2 main protease (Mpro), promoting osteogenesis in periodontitis, and alleviating atherosclerosis through FGF21/SREBP-2 signaling. It is also used in cosmetics for its pigment and skin-protective effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sappanwood.